- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), announced today that its Nano eNabler(tm) system has been named one of the 25 most innovative products of 2007 by the editors of R&D Magazine and the MICRO/NANO newsletter in the inaugural competition for products dedicated to micro and nanotechnology. Editorial Director for the publications, Tim Studt, explains, "These products, processes, and innovations are groundbreaking technologies that are likely to have a large impact on their specific industries and society."
The Nano eNabler system is a unique technology for fusing biological and non-biological nanomaterials. BioForce has used the Nano eNabler system to create a line of advanced BioNano products for healthcare. The system is also sold to researchers in academia and industry working in a broad range of areas including biomarker screening, cancer cell biology, nanosensors, stem cell research, and tissue engineering.
"BioForce Nanosciences is honored to be a recipient of this award from R&D Magazine for the Nano eNabler system," stated BioForce's Founder and CEO, Dr. Eric Henderson. "To be recognized by magazines and professionals of this caliber further strengthens our conviction that BioForce's vision to merge biology and nanotechnology to create advanced products for personalized medicine is achievable," concluded Henderson. An article on all 25 of this year's winners appeared in the July 2007 issue of MICRO/NANO newsletter and the August 2007 issue of R&D Magazine.
About BioForce Nanosciences, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. BioForce's flagship product, the Nano eNabler(tm) molecular printer, gives the Company a platform for development and discovery. BioForce technology is being used in sensor functionalization; patterning and cell adhesion; and printing proteins to guide neural cell growth. For more information, visit http://www.bioforcenano.com or call 515-233-8333.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the Company's most recent filings with the Securities and Exchange Commission. The Company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
For more information, please click here
RedChip Companies Inc.
1-800-REDCHIP (733-2447) ext 111
BioForce Nanosciences, Inc.
Greg Brown, CFO
515 233 8333 x118
Copyright © PrimeNewswireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
Graphene under pressure August 26th, 2016